A Phase 1b/2 Study of the Combination Isatuximab, Iberdomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible or Not Intended for Upfront Transplant
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Related studies linked through entity extraction aliases.